Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 64,575 | 55,011 | 45,961 | 36,461 | 33,046 |
| Operating Income | -64,575 | -55,011 | -45,961 | -36,461 | -33,046 |
| Other Income | 3,390 | 4,309 | 4,559 | 4,825 | 2,420 |
| Pre-tax Income | -61,185 | -50,702 | -41,402 | -31,636 | -30,626 |
| Income Tax | -155 | 33 | -159 | -50 | N/A |
| Net Income Continuous | -61,030 | -50,735 | -41,243 | -31,586 | -30,509 |
| Net Income | $-61,030 | $-50,735 | $-41,243 | $-31,586 | $-30,509 |
| EPS Basic Total Ops | -0.60 | -0.50 | -0.41 | -0.32 | 47.32 |
| EPS Basic Continuous Ops | -0.59 | -0.50 | -0.41 | -0.32 | 47.32 |
| EPS Diluted Total Ops | -0.60 | -0.50 | -0.41 | -0.32 | 47.32 |
| EPS Diluted Continuous Ops | -0.59 | -0.50 | -0.41 | -0.32 | 47.32 |
| EBITDA(a) | $-63,180 | $-54,534 | $-45,874 | $-36,989 | $-33,660 |